JP2023549098A5 - - Google Patents
Info
- Publication number
- JP2023549098A5 JP2023549098A5 JP2023526375A JP2023526375A JP2023549098A5 JP 2023549098 A5 JP2023549098 A5 JP 2023549098A5 JP 2023526375 A JP2023526375 A JP 2023526375A JP 2023526375 A JP2023526375 A JP 2023526375A JP 2023549098 A5 JP2023549098 A5 JP 2023549098A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- receptor
- cells
- car
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063109842P | 2020-11-04 | 2020-11-04 | |
| US63/109,842 | 2020-11-04 | ||
| US202163228490P | 2021-08-02 | 2021-08-02 | |
| US63/228,490 | 2021-08-02 | ||
| PCT/US2021/072255 WO2022099297A1 (en) | 2020-11-04 | 2021-11-04 | Multiplexed engineered ipsc and immune effector cells targeting solid tumors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549098A JP2023549098A (ja) | 2023-11-22 |
| JP2023549098A5 true JP2023549098A5 (https=) | 2024-11-13 |
Family
ID=81456848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023526375A Pending JP2023549098A (ja) | 2020-11-04 | 2021-11-04 | 固形腫瘍を標的とする多重操作されたｉＰＳＣ及び免疫エフェクター細胞 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230381235A1 (https=) |
| EP (1) | EP4240834A4 (https=) |
| JP (1) | JP2023549098A (https=) |
| KR (1) | KR20230096110A (https=) |
| AU (1) | AU2021376382A1 (https=) |
| CA (1) | CA3196555A1 (https=) |
| IL (1) | IL302481A (https=) |
| MX (1) | MX2023004326A (https=) |
| WO (1) | WO2022099297A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230118887A (ko) | 2020-12-03 | 2023-08-14 | 센츄리 쎄라퓨틱스 인코포레이티드 | 유전자 조작 세포 및 이의 용도 |
| US11661459B2 (en) | 2020-12-03 | 2023-05-30 | Century Therapeutics, Inc. | Artificial cell death polypeptide for chimeric antigen receptor and uses thereof |
| AR124414A1 (es) | 2020-12-18 | 2023-03-22 | Century Therapeutics Inc | Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable |
| US20230288405A1 (en) * | 2022-01-20 | 2023-09-14 | 3T Biosciences, Inc. | T cell receptor (tcr) compositions and methods for optimizing antigen reactive t-cells |
| AU2023273018A1 (en) * | 2022-05-18 | 2024-11-14 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Production and/or delivery of multispecific binding agents |
| GB202208545D0 (en) * | 2022-06-10 | 2022-07-27 | Adaptimmune Ltd | Production of immune cells |
| WO2025064828A1 (en) * | 2023-09-20 | 2025-03-27 | Kure.Ai, Inc. | Methods and reagents to improve cell therapy with the creation of novel car-targeting mr1 protein |
| GB202318950D0 (en) * | 2023-12-12 | 2024-01-24 | Adaptimmune Ltd | Production of immune cells |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201717578D0 (en) * | 2017-10-26 | 2017-12-13 | Univ College Cardiff Consultants Ltd | Novel T-cell receptor |
| CA3177757A1 (en) * | 2018-02-16 | 2019-08-22 | Kite Pharma, Inc. | Modified pluripotent stem cells and methods of making and use |
| WO2019204683A1 (en) * | 2018-04-19 | 2019-10-24 | Board Of Regents, The University Of Texas System | T cell receptors with mage-b2 specificity and uses thereof |
| EP3632460A1 (en) * | 2018-10-05 | 2020-04-08 | St. Anna Kinderkrebsforschung | A group of chimeric antigen receptors (cars) |
| KR20210139472A (ko) * | 2019-04-11 | 2021-11-22 | 페이트 세러퓨틱스, 인코포레이티드 | 조작된 iPSC 및 면역 효과기 세포에서의 CD3 재구성 |
| US20220213198A1 (en) * | 2019-05-22 | 2022-07-07 | The Council Of The Queensland Institute Of Medical Research | Method of treatment |
-
2021
- 2021-11-04 KR KR1020237018628A patent/KR20230096110A/ko active Pending
- 2021-11-04 EP EP21890337.5A patent/EP4240834A4/en active Pending
- 2021-11-04 IL IL302481A patent/IL302481A/en unknown
- 2021-11-04 US US18/250,737 patent/US20230381235A1/en active Pending
- 2021-11-04 AU AU2021376382A patent/AU2021376382A1/en active Pending
- 2021-11-04 JP JP2023526375A patent/JP2023549098A/ja active Pending
- 2021-11-04 WO PCT/US2021/072255 patent/WO2022099297A1/en not_active Ceased
- 2021-11-04 MX MX2023004326A patent/MX2023004326A/es unknown
- 2021-11-04 CA CA3196555A patent/CA3196555A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022550899A5 (https=) | ||
| JP2021505131A5 (https=) | ||
| JP2022541441A5 (https=) | ||
| JP2023549098A5 (https=) | ||
| JP2022548943A5 (https=) | ||
| JP2022510207A5 (https=) | ||
| JP2023548467A5 (https=) | ||
| JP2023548829A5 (https=) | ||
| JP7623020B2 (ja) | 同種異系移植のための操作された免疫細胞 | |
| JP2023530704A5 (https=) | ||
| JP2021519061A5 (https=) | ||
| JP2023505206A5 (https=) | ||
| JP7767502B2 (ja) | Ｎｋ阻害性分子を発現する遺伝子改変免疫細胞とその使用 | |
| JP2023545992A5 (https=) | ||
| JP2024518011A5 (https=) | ||
| WO2015028444A1 (en) | Anti cd30 chimeric antigen receptor and its use | |
| CN114015656A (zh) | 用于同种异体移植的工程化免疫细胞 | |
| KR20230137923A (ko) | 신규한 키메라 항원 수용체 및 이의 용도 | |
| EP4194472A1 (en) | Chimeric antigen receptor comprising novel co-stimulatory domain and use thereof | |
| KR20210126008A (ko) | 세포 면역 치료의 조합 | |
| KR20210018838A (ko) | 유전자 조작된 세포 및 응용 | |
| CN111542545A (zh) | Cd38定向嵌合抗原受体构建体 | |
| US20220133792A1 (en) | Signaling platforms for chimeric antigen receptor t cells | |
| JP2024515920A5 (https=) | ||
| JP2024526237A5 (https=) |